NCT06058091View on ClinicalTrials.gov

RY_SW01 Cell Injection Therapy in Systemic Sclerosis

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

September 22, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2035

Conditions
Systemic Sclerosis
Interventions
DRUG

RY_SW01 cell injection

Administer basic treatment with an injection of RY\_SW01 cell solution

DRUG

Basic treatment

Basic treatment for SSc

Trial Locations (1)

210008

RECRUITING

Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing

All Listed Sponsors
collaborator

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

lead

Jiangsu Renocell Biotech Company

INDUSTRY